PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) announced the distribution of quality improvement research grants to advance care for patients with Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL). Funded by AstraZeneca, these initiatives aim to enhance treatment access, address disparities, and improve quality of life for patients.
CLL/SLL is the most common leukemia type in the U.S., with approximately 20,000 new cases annually. Despite treatment advances, many patients, particularly older adults and those in underserved communities, face challenges in receiving optimal care. The newly selected research projects are designed to address these gaps and promote better outcomes.
The three grants have been awarded to the following projects and investigators:
- Larry Cripe, MD, Indiana University Melvin and Bren Simon Comprehensive Cancer Center
“The CLL/SLL Care Road Map” – This project aims to develop interactive web-based tools to help patients make informed treatment decisions. - Alessandra Ferrajoli, MD, The University of Texas MD Anderson Cancer Center
“Improving Detection of Other Cancers in CLL Patients” – Using advanced multicancer early detection testing, this initiative seeks to identify additional cancers for timely intervention. - Sara Tinsley-Vance, PhD, APRN, Moffitt Cancer Center
“Predictors of Health-Related Quality of Life in Adults with CLL/SLL” – This study will explore factors that influence patients’ quality of life, aiming to enhance supportive care.
“Despite advances in treatment, many patients with CLL/SLL, particularly those from underserved communities, are not receiving care that aligns with current clinical guidelines,” said Dr. Crystal S. Denlinger, Chief Executive Officer of NCCN. “We are hoping to increase access to optimal care in order to improve outcomes and the overall quality of life for these patients.”
The grants exemplify a continued commitment to bridging gaps in cancer care and ensuring equitable treatment for all patients. Proposals for the project were peer-reviewed by a scientific committee of experts from NCCN Member Institutions.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.